Yaopharma Co., Ltd.

Form 483 issued March 29, 2019 · Chongqing, China

Inspection
Mar 25 – Mar 29, 2019
Investigator
Jose O. Hernandez
Observations
1
Pages
1
FEI number
3008309828

In short: On March 29, 2019, FDA issued a Form 483 with 1 observation to Yaopharma Co., Ltd. in Chongqing, China (FEI 3008309828) after an inspection that ran Mar 25 – Mar 29, 2019. The investigator was Jose O. Hernandez. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written production and process control procedures are not followed in the execution of production and process…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Yaopharma Co., Ltd.?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected Yaopharma Co., Ltd.?

Jose O. Hernandez is named on this Form 483, for the inspection of Mar 25 – Mar 29, 2019. Each investigator has a profile showing what they cite most.

When was Yaopharma Co., Ltd. inspected by FDA?

The inspection ran Mar 25 – Mar 29, 2019, and the Form 483 is dated March 29, 2019.

How do I get the full Form 483 for Yaopharma Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free